Showing results (61-70 of 198) with videos related to
Sort By:
Pageof 20
Pneumologie (Stuttgart, Germany)|July 14, 2001
[Preventive monotherapy with montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot study]C Liebke, C Sommerfeld, U Wahn, et al.International Archives of Allergy and Immunology|August 1, 1994
Serum tryptase and urinary 1-methylhistamine as parameters for monitoring oral food challenges in childrenK Beyer, B Niggemann, S Schulze, et al.Allergy|September 3, 2017
Hen's egg allergen in house and bed dust is significantly increased after hen's egg consumption-A pilot studyV Trendelenburg, S Tschirner, B Niggemann, et al.Mediators of Inflammation|January 1, 1995
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infectionB Niggemann, T Stiller, K Magdorf, et al.Allergy|February 1, 1994
Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic childrenB Niggemann, I Kleinau, M Schmitt, et al.Allergy|January 1, 1993
Monitoring of inflammation during challenge tests in childrenU Wahn, B Niggemann, I Kleinau, et al.Journal of Pediatric Surgery|October 5, 2001
Latex allergy in pediatric surgery is dependent on repeated operations in the first year of lifeP Degenhardt, S Golla, F Wahn, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 2014
Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challengeB Ahrens, B Niggemann, U Wahn, et al.The Journal of Allergy and Clinical Immunology|November 5, 1998
Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic?B Niggemann, D Buck, T Michael, et al.Acta Endocrinologica. Supplementum|January 1, 1986
Urinary arginine-vasopressin (AVP) excretion in cystic fibrosis (CF)H Stegner, S Caspers, B Niggemann, et al.Pageof 20